Skip to main content
NIH funding notice RFA-RM-18-016

Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)

Closed on April 3, 2018.

Posted
January 24, 2018
Close date
April 3, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,129,951 in first-year total cost, median $818,063.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 GGG-D (70)]9

Most frequent institutions

  1. UNIV OF MASSACHUSETTS MED SCH WORCESTER2
  2. BETH ISRAEL DEACONESS MEDICAL CENTER1
  3. BROAD INSTITUTE, INC.1
  4. DUKE UNIVERSITY1
  5. MASSACHUSETTS EYE AND EAR INFIRMARY1
Competing awards under RFA-RM-18-016 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Novel AAVs engineered for efficient and noninvasive cross-species gene editing throughout the central nervous system1UG3NS111689-01DEVERMAN, BENJAMIN EBROAD INSTITUTE, INC., MA$846,261ZRG1
2018Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles1UG3TR002636-01CHEN, ZHENG-YILIU, DAVID RXU, QIAOBINGMASSACHUSETTS EYE AND EAR INFIRMARY, MA$831,027ZRG1
2018Develop combinatorial non-viral and viral CRISPR delivery for lung diseases1UG3HL147367-01ANDERSON, DANIEL GGAO, GUANGPINGXUE, WENUNIV OF MASSACHUSETTS MED SCH WORCESTER, MA$826,169ZRG1
2018Enhancing CRISPR Gene Editing in Somatic Tissues by Chemical Modification of Guides and Donors1UG3TR002668-01KHVOROVA, ANASTASIASONTHEIMER, ERIK J.WATTS, JONATHAN KWOLFE, SCOT AUNIV OF MASSACHUSETTS MED SCH WORCESTER, MA$826,025ZRG1
2018Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung1UG3HL147352-01GLAZER, PETER MSALTZMAN, W. MARKYALE UNIVERSITY, CT$818,063ZRG1
2018Bioengineered red blood cells as extracellular vesicle-mediated delivery platforms for gene editing machinery1UG3HL147353-01GHIRAN, IONITA CALINBETH ISRAEL DEACONESS MEDICAL CENTER, MA$798,810ZRG1
2018Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain1UG3NS111688-01EMBORG, MARINAGONG, SHAOQIN -LEVINE, JON EROY, SUBHOJITSAHA, KRISHANUUNIVERSITY OF WISCONSIN-MADISON, WI$752,280ZRG1
2018Evolving High Potency AAV Vectors for Neuromuscular Genome Editing1UG3AR075336-01ASOKAN, ARAVINDDUKE UNIVERSITY, NC$746,139ZRG1
2018Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides1UG3HL147366-01MCCRAY, PAUL BUNIVERSITY OF IOWA, IA$685,177ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-RM-18-016: Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) | ScienceDex | ConductScience